Four things to know:
1. The government-appointed drug affordability board will set limits on how much state and local governments pay for high-cost prescription medications. The goal is to lower prescription drug-spending in the state.
2. Barring a veto from Maryland’s governor, the board would be established by 2022.
3. The drug industry’s leading trade group, Pharmaceutical Research and Manufacturers of America, opposes the legislation creating the board, calling it “dangerous” and “unconstitutional.” The group said it could lead to delays and other challenges for patients.
4. The pharmaceutical industry likely will challenge the law creating the board in court.
Read the full report here.
More articles on pharmacy:
PBM hearing should prompt bill to ban ‘secrecy’ in drug industry, senator says
Republicans tell drugmakers that complying with House probe could hurt their stock prices
Hawaii primary care network opens in-house pharmacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.